These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17709099)

  • 1. Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia?
    Schuster C; Fernbach N; Rix U; Superti-Furga G; Holy M; Freissmuth M; Sitte HH; Sexl V
    Biochem Pharmacol; 2007 Nov; 74(9):1424-35. PubMed ID: 17709099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proapoptotic and chemosensitizing effects of selective serotonin reuptake inhibitors on T cell lymphoma/leukemia (Jurkat) in vitro.
    Amit BH; Gil-Ad I; Taler M; Bar M; Zolokov A; Weizman A
    Eur Neuropsychopharmacol; 2009 Oct; 19(10):726-34. PubMed ID: 19631512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells.
    Serafeim A; Holder MJ; Grafton G; Chamba A; Drayson MT; Luong QT; Bunce CM; Gregory CD; Barnes NM; Gordon J
    Blood; 2003 Apr; 101(8):3212-9. PubMed ID: 12515726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In response to "Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia?" by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424-1435].
    Gordon J; Barnes N; Meredith E; Drayson M
    Biochem Pharmacol; 2008 Mar; 75(6):e1-3; author reply e4-5. PubMed ID: 18319082
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxicity of different selective serotonin reuptake inhibitors (SSRIs) against cancer cells.
    Rosetti M; Frasnelli M; Tesei A; Zoli W; Conti M
    J Exp Ther Oncol; 2006; 6(1):23-9. PubMed ID: 17228521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors.
    Serafeim A; Grafton G; Chamba A; Gregory CD; Blakely RD; Bowery NG; Barnes NM; Gordon J
    Blood; 2002 Apr; 99(7):2545-53. PubMed ID: 11895792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Anti-tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells.
    Kuwahara J; Yamada T; Egashira N; Ueda M; Zukeyama N; Ushio S; Masuda S
    Biol Pharm Bull; 2015; 38(9):1410-4. PubMed ID: 26328498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines.
    Zagorodna O; Martin SM; Rutkowski DT; Kuwana T; Spitz DR; Knudson CM
    Oncogene; 2012 May; 31(22):2738-49. PubMed ID: 21986940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology.
    Goodnick PJ; Goldstein BJ
    J Psychopharmacol; 1998; 12(3 Suppl B):S5-20. PubMed ID: 9808077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.
    Isaac R; Boura-Halfon S; Gurevitch D; Shainskaya A; Levkovitz Y; Zick Y
    J Biol Chem; 2013 Feb; 288(8):5682-93. PubMed ID: 23275337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors and raft inhibitors shorten the period of Period1-driven circadian bioluminescence rhythms in rat-1 fibroblasts.
    Nomura K; Castanon-Cervantes O; Davidson A; Fukuhara C
    Life Sci; 2008 Jun; 82(23-24):1169-74. PubMed ID: 18482738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function.
    Hodge JM; Wang Y; Berk M; Collier FM; Fernandes TJ; Constable MJ; Pasco JA; Dodd S; Nicholson GC; Kennedy RL; Williams LJ
    Biol Psychiatry; 2013 Jul; 74(1):32-9. PubMed ID: 23260229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms.
    Frick LR; Palumbo ML; Zappia MP; Brocco MA; Cremaschi GA; Genaro AM
    Biochem Pharmacol; 2008 May; 75(9):1817-26. PubMed ID: 18342838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics.
    Meredith EJ; Holder MJ; Chamba A; Challa A; Drake-Lee A; Bunce CM; Drayson MT; Pilkington G; Blakely RD; Dyer MJ; Barnes NM; Gordon J
    FASEB J; 2005 Jul; 19(9):1187-9. PubMed ID: 15870169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats.
    Kitaichi Y; Inoue T; Nakagawa S; Boku S; Kakuta A; Izumi T; Koyama T
    Eur J Pharmacol; 2010 Nov; 647(1-3):90-6. PubMed ID: 20816814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).
    Hyttel J
    Int Clin Psychopharmacol; 1994 Mar; 9 Suppl 1():19-26. PubMed ID: 8021435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and potentiation of parturition in fingernail clams (Sphaerium striatinum) by selective serotonin re-uptake inhibitors (SSRIs).
    Fong PP; Huminski PT; D'Urso LM
    J Exp Zool; 1998 Feb; 280(3):260-4. PubMed ID: 9472482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.